Diabetes Board decisions

The Board granted an initial rating of 20 percent for tendinitis of the right foot and remanded claims for service connection for diabetes mellitus, type II, and eligibility for financial assistance in the purchase of one automobile or other conveyance and/or automobile adaptive equipment.

The Veteran is granted a total disability rating based on individual unemployability due to his service-connected low back disability and associated lower extremity radiculopathies. Service connection for diabetes mellitus is denied.

The Board remands the service connection claim for diabetes mellitus, type II to obtain a new medical opinion regarding its etiology and whether it is secondary to any service-connected disabilities or medications used to treat such disabilities.

The Board granted readjudication of the claim for entitlement to a TDIU and denied service connection for heart, diabetes mellitus type II, and pancreatic cancer disabilities.

The Board granted service connection for coronary artery disease, status post dual chamber ICD placement residual scar, type II diabetes mellitus, and hypertension with an effective date of October 29, 2020.

The appeal was dismissed due to the death of the appellant.

The Board denied the claim for Dependency and Indemnity Compensation (DIC) under 38 U.S.C. § 1318, as the Veteran was not rated totally disabled due to service-connected disabilities at any time preceding his death.

The Board granted service connection for a heart condition manifest by cardiac arrhythmia, diabetes mellitus, type II, prostate cancer, hypertension, and eczema based on presumptive exposure to herbicide agents during active service.

The Board granted a separate 60 percent rating for diabetic nephropathy based on chronic kidney disease with GFR from 30 to 44 mL/min/1.73 m2 for at least 3 consecutive months during the past 12 months.

The Board granted service connection for diabetes mellitus, left lower extremity diabetic peripheral neuropathy, right lower extremity diabetic peripheral neuropathy, and erectile dysfunction. The CAD rating was increased to 60 percent effective February 23, 2021.

The Board denied service connection for diabetes, a bilateral shoulder disorder, sinusitis, allergic rhinitis, and rheumatoid arthritis as there is no evidence of current disabilities. The claims for hypertension, back disorder, foot disorder, hip disorder, and peripheral neuropathy were remanded for further development.

The Board denied service connection for diabetes mellitus, type II, hypertension, heart disease (congestive heart failure with arteriosclerotic heart disease, valvular heart disease, cardiomegaly and aortic aneurysm), and hyperlipidemia as the evidence did not support that these conditions were incurred in or aggravated by service.

The Board granted service connection for diabetes mellitus type II, finding a causal relationship between the Veteran's in-service exposure to airborne particulates and lead. The claim for chronic prostatitis was remanded for further development.

The Board granted service connection for diabetes mellitus type 2 and an initial 40 percent rating for IVDS, while denying higher ratings for radiculopathy of the lower extremities, a residual scar, and bilateral foot disability. The effective date for TDIU and DEA benefits was also granted.

The Board granted service connection for left eye optic nerve damage as secondary to the service-connected disability of diabetes mellitus with erectile dysfunction.

The Board remands the claims for service connection for sleep apnea and diabetes mellitus type II due to a pre-decisional duty to assist error, as the RO did not provide the Veteran with VA examinations.

The Board denied the Veteran's claim for service connection for diabetes mellitus, type II, and remanded claims for an increased rating for lumbar spine disability and TDIU.

The Board denied service connection for diabetes mellitus as it did not have its onset during active service or within one year of discharge, and is not causally related to any disease, injury, or event during active service.

The Board remands the claims for service connection for diabetes mellitus type II, hypertension, atrial fibrillation, sleep apnea syndrome, and mycosis fungoides (also claimed as skin cancer) to ensure the VA has met a duty to assist the Veteran.

The Board denied the Veteran's claim for service connection for diabetes mellitus, type II, as there was no evidence of in-service exposure to herbicide agents and the disease did not manifest during or within one year of service.